Millendo Therapeutics, Inc. - MLND

SEC FilingsOur MLND Tweets

About Gravity Analytica

Recent News

    Recent Filings

    • 02.06.2025 - 424B5 Prospectus [Rule 424(b)(5)]
    • 01.27.2025 - EFFECT Notice of Effectiveness
    • 01.24.2025 - S-3/A Registration statement under Securities Act of 1933
    • 01.06.2025 - 4 Statement of changes in beneficial ownership of securities
    • 12.31.2024 - 8-K Current report
    • 11.12.2024 - EX-99.1 EX-99.1
    • 11.12.2024 - DEF 14A Other definitive proxy statements
    • 11.12.2024 - 10-Q Quarterly report [Sections 13 or 15(d)]
    • 10.29.2024 - PRE 14A Other preliminary proxy statements
    • 10.10.2024 - 8-A12B/A Registration of securities [Section 12(b)]